COMP <GO>
CAH vs UNH // ENTERPRISE SCALE & MARKET CAP
Cardinal Health Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CAH 5
— UNH 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $250.48 (-0.24%) • MKT CAP: $58.14B
market-cap
$58.14B
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
market-cap
$364.66B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CAH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CAH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.70% | 88.57% | -84.87 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.70% | 11.47% | +18.23 | CAH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.5x | 16.4x | +8.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 3.18% | 6.48% | -3.30 | UNH | /fcf-yield <GO> |
| Operating Margin | 1.00% | 4.82% | -3.82 | UNH | /operating-margins <GO> |
| Net Profit Margin | 0.70% | 3.14% | -2.44 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -1.90% | 6.46% | -8.36 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.85% | 2.28% | -1.43 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.16 | 3.12 | +2.04 | CAH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.74% | -0.14 | CAH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.5 | 56.0 | +2.40 | CAH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.33 | +0.57 | CAH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.6x | 17.1x | +17.51 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $58.14B | $364.66B | -$306.52B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CAH REV | UNH REV | CAH GROSS % | UNH GROSS % | CAH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $222.58B | $447.57B | 3.7% | 88.7% | $1.85B | $16.07B |
| FY 2024 | $226.83B | $400.28B | 3.3% | 88.3% | $3.25B | $20.70B |
| FY 2023 | $204.98B | $371.62B | 44.0% | 89.6% | -$6.38B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CAH // BETA 0.90
UNH // BETA 0.33